These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21841657)

  • 1. The capsaicin 8% patch for peripheral neuropathic pain.
    England J; Wagner T; Kern KU; Roth-Daniek A; Sell A
    Br J Nurs; 2011 Aug 11-Sep 8; 20(15):926-31. PubMed ID: 21841657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
    Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
    Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsaicin 8% patch for peripheral neuropathic pain: review of treatment best practice from 'real-world' clinical experience.
    Wagner T; Roth-Daniek A; Sell A; England J; Kern KU
    Pain Manag; 2012 May; 2(3):239-50. PubMed ID: 24654666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the capsaicin 8% cutaneous patch in neuropathic pain of the head and face: A case series.
    Gaul C; Resch S
    Cephalalgia; 2015 May; 35(6):545-50. PubMed ID: 25217483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
    Maihofner C; Heskamp ML
    Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain.
    Treede RD; Wagner T; Kern KU; Husstedt IW; Arendt G; Birklein F; Cegla T; Freynhagen R; Gockel HH; Heskamp ML; Jager H; Joppich R; Maier C; Leffler A; Nagelein HH; Rolke R; Seddigh S; Sommer C; Stander S; Wasner G; Baron R
    Curr Med Res Opin; 2013 May; 29(5):527-38. PubMed ID: 23444968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsaicin. Neuropathic pain: playing with fire...
    Prescrire Int; 2010 Aug; 19(108):153-5. PubMed ID: 20939441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
    Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
    Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
    Tenreiro Pinto J; Pereira FC; Loureiro MC; Gama R; Fernandes HL
    Pharmacology; 2018; 101(5-6):290-297. PubMed ID: 29587275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain.
    Raber JM; Reichelt D; Grüneberg-Oelker U; Philipp K; Stubbe-Dräger B; Husstedt IW
    Acta Neurol Belg; 2015 Sep; 115(3):335-43. PubMed ID: 25421590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsaicin 8% Patch for Central and Peripheral Neuropathic Pain of Persons with Incomplete Spinal Cord Injury: Two Case Reports.
    Trbovich M; Yang H
    Am J Phys Med Rehabil; 2015 Aug; 94(8):e66-72. PubMed ID: 26035723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttraumatic and postsurgical neuropathic pain responsive to treatment with capsaicin 8% topical patch.
    Zis P; Apsokardos A; Isaia C; Sykioti P; Vadalouca A
    Pain Physician; 2014; 17(2):E213-8. PubMed ID: 24658488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia.
    Wallace M; Pappagallo M
    Expert Rev Neurother; 2011 Jan; 11(1):15-27. PubMed ID: 21158551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).
    Katz NP; Mou J; Paillard FC; Turnbull B; Trudeau J; Stoker M
    Clin J Pain; 2015 Oct; 31(10):859-66. PubMed ID: 25503598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
    Wagner T; Poole C; Roth-Daniek A
    Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsaicin 8% topical patch (Qutenza)--a review of the evidence.
    Jones VM; Moore KA; Peterson DM
    J Pain Palliat Care Pharmacother; 2011; 25(1):32-41. PubMed ID: 21426216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain.
    Babbar S; Marier JF; Mouksassi MS; Beliveau M; Vanhove GF; Chanda S; Bley K
    Ther Drug Monit; 2009 Aug; 31(4):502-10. PubMed ID: 19494795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study.
    Jensen TS; Høye K; Fricová J; Vanelderen P; Ernault E; Siciliano T; Marques S
    Eur J Pain; 2014 Oct; 18(9):1240-7. PubMed ID: 24664539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effective pain relief of post-herpetic neuralgia with capsaicin patch].
    Andersen HH; Sand C; Elberling J
    Ugeskr Laeger; 2016 Feb; 178(5):V10150846. PubMed ID: 26857302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.